Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.

Zuniga A, Liniger M, Morin TN, Marty RR, Wiegand M, Ilter O, Weibel S, Billeter MA, Knuchel MC, Naim HY.

Hum Vaccin Immunother. 2013 Mar;9(3):607-13. Epub 2013 Jan 16.

2.

Comments on "Gene and genon concept" by K. Scherrer and J. Jost.

Billeter MA.

Theory Biosci. 2009 Aug;128(3):163-4; discussion 171-7. doi: 10.1007/s12064-009-0068-x. No abstract available.

PMID:
19779755
3.

Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses.

Billeter MA, Naim HY, Udem SA.

Curr Top Microbiol Immunol. 2009;329:129-62. Review.

PMID:
19198565
4.

Attenuated measles virus as a vaccine vector.

Zuniga A, Wang Z, Liniger M, Hangartner L, Caballero M, Pavlovic J, Wild P, Viret JF, Glueck R, Billeter MA, Naim HY.

Vaccine. 2007 Apr 20;25(16):2974-83. Epub 2007 Feb 2.

5.

Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses.

Hoffman SJ, Polack FP, Hauer DA, Singh M, Billeter MA, Adams RJ, Griffin DE.

J Infect Dis. 2003 Nov 15;188(10):1553-61. Epub 2003 Oct 28.

PMID:
14624382
6.

Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion.

Ehrengruber MU, Ehler E, Billeter MA, Naim HY.

J Virol. 2002 Jun;76(11):5720-8.

7.

Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease.

Patterson JB, Cornu TI, Redwine J, Dales S, Lewicki H, Holz A, Thomas D, Billeter MA, Oldstone MB.

Virology. 2001 Dec 20;291(2):215-25.

8.

Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses.

Wang Z, Hangartner L, Cornu TI, Martin LR, Zuniga A, Billeter MA, Naim HY.

Vaccine. 2001 Mar 21;19(17-19):2329-36.

PMID:
11257357
9.

Roles of macrophages in measles virus infection of genetically modified mice.

Roscic-Mrkic B, Schwendener RA, Odermatt B, Zuniga A, Pavlovic J, Billeter MA, Cattaneo R.

J Virol. 2001 Apr;75(7):3343-51.

10.
11.

V and C proteins of measles virus function as virulence factors in vivo.

Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB.

Virology. 2000 Feb 1;267(1):80-9.

12.

Recombinant measles virus requiring an exogenous protease for activation of infectivity.

Maisner A, Mrkic B, Herrler G, Moll M, Billeter MA, Cattaneo R, Klenk HD.

J Gen Virol. 2000 Feb;81(Pt 2):441-9.

PMID:
10644843
13.

Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice.

Mrkic B, Odermatt B, Klein MA, Billeter MA, Pavlovic J, Cattaneo R.

J Virol. 2000 Feb;74(3):1364-72.

14.
15.

The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain.

Duprex WP, Duffy I, McQuaid S, Hamill L, Cosby SL, Billeter MA, Schneider-Schaulies J, ter Meulen V, Rima BK.

J Virol. 1999 Aug;73(8):6916-22.

16.

A functional measles virus replication and transcription machinery encoded by the vaccinia virus genome.

Howley PM, Lafont B, Spehner D, Kaelin K, Billeter MA, Drillien R.

J Virol Methods. 1999 Apr;79(1):65-74.

PMID:
10328536
18.

A recombinant measles virus expressing biologically active human interleukin-12.

Singh M, Billeter MA.

J Gen Virol. 1999 Jan;80 ( Pt 1):101-6.

PMID:
9934691
19.

Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis.

Tober C, Seufert M, Schneider H, Billeter MA, Johnston IC, Niewiesk S, ter Meulen V, Schneider-Schaulies S.

J Virol. 1998 Oct;72(10):8124-32.

20.

Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo.

Valsamakis A, Schneider H, Auwaerter PG, Kaneshima H, Billeter MA, Griffin DE.

J Virol. 1998 Oct;72(10):7754-61.

21.

T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses.

Fehr T, Naim HY, Bachmann MF, Ochsenbein AF, Spielhofer P, Bucher E, Hengartner H, Billeter MA, Zinkernagel RM.

Nat Med. 1998 Aug;4(8):945-8.

PMID:
9701248
22.

A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain.

Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA, Cattaneo R.

EMBO J. 1998 Jul 15;17(14):3899-908.

23.

Chimeric measles viruses with a foreign envelope.

Spielhofer P, Bächi T, Fehr T, Christiansen G, Cattaneo R, Kaelin K, Billeter MA, Naim HY.

J Virol. 1998 Mar;72(3):2150-9.

24.

Reverse Genetics Meets the Nonsegmented Negative-Strand RNA Viruses.

Radecke F, Billeter MA.

Rev Med Virol. 1997 Apr;7(1):49-63. No abstract available.

PMID:
10398469
25.

Rescue of measles virus using a replication-deficient vaccinia-T7 vector.

Schneider H, Spielhofer P, Kaelin K, Dötsch C, Radecke F, Sutter G, Billeter MA.

J Virol Methods. 1997 Feb;64(1):57-64.

PMID:
9029530
26.
27.

Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro.

Schlender J, Schnorr JJ, Spielhoffer P, Cathomen T, Cattaneo R, Billeter MA, ter Meulen V, Schneider-Schaulies S.

Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13194-9.

29.

Rescue of measles viruses from cloned DNA.

Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dötsch C, Christiansen G, Billeter MA.

EMBO J. 1995 Dec 1;14(23):5773-84.

30.

Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene.

Sidhu MS, Chan J, Kaelin K, Spielhofer P, Radecke F, Schneider H, Masurekar M, Dowling PC, Billeter MA, Udem SA.

Virology. 1995 Apr 20;208(2):800-7.

31.

A comparison of nucleotide sequences of measles virus L genes derived from wild-type viruses and SSPE brain tissues.

Komase K, Rima BK, Pardowitz I, Kunz C, Billeter MA, ter Meulen V, Baczko K.

Virology. 1995 Apr 20;208(2):795-9.

PMID:
7747453
32.

Appendix: measles virus antigenome and protein consensus sequences.

Radecke F, Billeter MA.

Curr Top Microbiol Immunol. 1995;191:181-92. Review. No abstract available.

PMID:
7789160
33.

Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis.

Billeter MA, Cattaneo R, Spielhofer P, Kaelin K, Huber M, Schmid A, Baczko K, ter Meulen V.

Ann N Y Acad Sci. 1994 Jun 6;724:367-77. Review.

PMID:
8030963
34.

Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus.

Schmid A, Spielhofer P, Cattaneo R, Baczko K, ter Meulen V, Billeter MA.

Virology. 1992 Jun;188(2):910-5.

PMID:
1585658
35.

Mutations and A/I hypermutations in measles virus persistent infections.

Cattaneo R, Billeter MA.

Curr Top Microbiol Immunol. 1992;176:63-74. Review. No abstract available.

PMID:
1600755
36.

Retraction. Infectious measles virus from cloned cDNA.

Eschle D, Cattaneo R, Schmid A, Metzler M, Chan J, Pifko-Hirst S, Udem SA, Billeter MA.

EMBO J. 1991 Nov;10(11):3558. No abstract available.

37.

Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm.

Huber M, Cattaneo R, Spielhofer P, Orvell C, Norrby E, Messerli M, Perriard JC, Billeter MA.

Virology. 1991 Nov;185(1):299-308.

PMID:
1656588
38.

Retraction. Functional and nonfunctional measles virus matrix genes from lethal human brain infections.

Huber M, Schmid A, Cattaneo R, Billeter MA.

J Virol. 1991 Oct;65(10):5656. No abstract available.

39.
40.

RNA editing. Sometimes an editor makes sense.

Weissmann C, Cattaneo R, Billeter MA.

Nature. 1990 Feb 22;343(6260):697-9. No abstract available.

PMID:
2304546
41.

Infectious measles virus from cloned cDNA.

Ballart I, Eschle D, Cattaneo R, Schmid A, Metzler M, Chan J, Pifko-Hirst S, Udem SA, Billeter MA.

EMBO J. 1990 Feb;9(2):379-84. Retraction in: Eschle D, Cattaneo R, Schmid A, Metzler M, Chan J, Pifko-Hirst S, Udem SA, Billeter MA. EMBO J. 1991 Nov;10(11):3558.

42.

Measles virus editing provides an additional cysteine-rich protein.

Cattaneo R, Kaelin K, Baczko K, Billeter MA.

Cell. 1989 Mar 10;56(5):759-64.

PMID:
2924348
43.

Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA.

Bass BL, Weintraub H, Cattaneo R, Billeter MA.

Cell. 1989 Feb 10;56(3):331. No abstract available.

PMID:
2914324
44.

Biased hypermutation and other genetic changes in defective measles viruses in human brain infections.

Cattaneo R, Schmid A, Eschle D, Baczko K, ter Meulen V, Billeter MA.

Cell. 1988 Oct 21;55(2):255-65.

PMID:
3167982
45.

Restriction of measles virus gene expression in measles inclusion body encephalitis.

Baczko K, Liebert UG, Cattaneo R, Billeter MA, Roos RP, ter Meulen V.

J Infect Dis. 1988 Jul;158(1):144-50.

PMID:
3164746
46.
47.

Altered ratios of measles virus transcripts in diseased human brains.

Cattaneo R, Rebmann G, Baczko K, ter Meulen V, Billeter MA.

Virology. 1987 Oct;160(2):523-6.

PMID:
3660593
48.

A procedure for selective full length cDNA cloning of specific RNA species.

Schmid A, Cattaneo R, Billeter MA.

Nucleic Acids Res. 1987 May 26;15(10):3987-96.

49.

Altered transcription of a defective measles virus genome derived from a diseased human brain.

Cattaneo R, Rebmann G, Schmid A, Baczko K, ter Meulen V, Billeter MA.

EMBO J. 1987 Mar;6(3):681-8.

50.

Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration.

Cattaneo R, Schmid A, Rebmann G, Baczko K, Ter Meulen V, Bellini WJ, Rozenblatt S, Billeter MA.

Virology. 1986 Oct 15;154(1):97-107.

PMID:
3750847

Supplemental Content

Loading ...
Support Center